McCarty C A, Nanjan M B, Taylor H R
Centre for Eye Research Australia, University of Melbourne, Royal Victorian Eye and Ear Hospital, Melbourne, Australia.
Br J Ophthalmol. 2001 Mar;85(3):322-6. doi: 10.1136/bjo.85.3.322.
To describe predictors of mortality in the 5 year follow up of the Melbourne Visual Impairment Project (VIP) cohort.
The Melbourne VIP was a population based study of the distribution and determinants of age related eye disease in a cluster random sample of Melbourne residents aged 40 years and older. Baseline examinations were conducted between 1992 and 1994. In 1997, 5 year follow up examinations of the original cohort commenced. Causes of death were obtained from the National Death Index for all reported deaths.
Of the original 3271 participants, 231 (7.1%) were reported to have died in the intervening 5 years. Of the remaining 3040 participants eligible to return for follow up examinations, 2594 (85% of eligible) did participate, 51 (2%) had moved interstate or overseas, 83 (3%) could not be traced, and 312 (10%) refused to participate. Best corrected visual acuity <6/12 (OR=2.34) was associated with a significantly increased risk of mortality, as were increasing age (OR=1.09), male sex (OR=1.62), increased duration of cigarette smoking (OR=2.06 for smoking >30 years), increased duration of hypertension (OR=1.51 for duration >10 years), and arthritis (OR=1.42).
Even mild visual impairment increases the risk of death more than twofold. Further research is needed to determine why decreased visual acuity is associated with increased risk of mortality.
描述墨尔本视力损害项目(VIP)队列5年随访中的死亡预测因素。
墨尔本VIP是一项基于人群的研究,对墨尔本40岁及以上居民的集群随机样本进行年龄相关性眼病的分布和决定因素研究。1992年至1994年进行了基线检查。1997年,对原队列开始进行5年随访检查。所有报告死亡的死因均从国家死亡指数中获取。
在最初的3271名参与者中,有231人(7.1%)报告在这5年期间死亡。在其余有资格返回进行随访检查的30旦0名参与者中,2594人(占符合条件者的85%)确实参与了,51人(2%)搬到了州际或海外,83人(3%)无法追踪到,312人(10%)拒绝参与。最佳矫正视力<6/12(比值比=2.34)与死亡风险显著增加相关,年龄增加(比值比=1.09)、男性(比值比=1.62)、吸烟时间延长(吸烟>30年时比值比=2.06)、高血压病程延长(病程>10年时比值比=1.51)以及关节炎(比值比=1.42)也与死亡风险显著增加相关。
即使是轻度视力损害也会使死亡风险增加两倍多。需要进一步研究以确定视力下降为何与死亡风险增加相关。